NASDAQ
No price data available for this timeframe.
Abbott Laboratories (ABT) has a consensus Buy rating from 41 analysts with an average price target of $127.46, representing +44.1% upside from the current price of $88.46.
| Date | Analyst | Firm | Target | Price | Upside |
|---|---|---|---|---|---|
| Apr 22, 2026 | Unknown | Daiwa | $92.00 | $92.75 | -0.80% |
| Apr 20, 2026 | Matt Miksic | Barclays | $143.00 | $96.83 | +47.68% |
| Apr 17, 2026 | Unknown | UBS | $115.00 | $95.46 | +20.47% |
| Apr 17, 2026 | Unknown | Piper Sandler | $115.00 | $95.46 |
Apr 27, 2026 | Maintained | BTIG | Buy | Buy |
Apr 20, 2026 | Maintained | Barclays | Overweight | Overweight |
Apr 17, 2026 | Maintained | BTIG | Buy | Buy |
Apr 17, 2026 | Maintained | B of A Securities | Buy | Buy |
Apr 17, 2026 | Maintained | Stifel | Buy | Buy |
| Apr 17, 2026 | Unknown | Stifel Nicolaus | $120.00 | $95.46 | +25.71% |